BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rutgers Addiction Research Center (RARC) - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.addiction.rutgers.edu
X-WR-CALDESC:Events for Rutgers Addiction Research Center (RARC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240606T100000
DTEND;TZID=America/New_York:20240606T120000
DTSTAMP:20260424T040357
CREATED:20240502T172912Z
LAST-MODIFIED:20240502T172912Z
UID:7186-1717668000-1717675200@www.addiction.rutgers.edu
SUMMARY:NJPN Webinar - Play and Protect: Female Athletes & Opioids
DESCRIPTION:Join us for this FREE webinar as we explore high school and college female athletics with a focus on mental health and opioids. \nTopics discussed will include: \nYouth Prevention \nAvailable resources to prevent opioid use disorder and evidence-based strategies to reduce youth and young adult opioid use. \nOpioids & Female Sports \nCommon risk & protective factors regarding opioid prescribing and high school and college girl’s and women’s sports. \nNaloxone (a.k.a. Narcan) \nThe importance of naloxone availability\, where/how to access it\, and upcoming potential policy changes and opportunities. \n\n\n\n\n\n\n\n\nPresented by the New Jersey Office of the Attorney General and the New Jersey Prevention Network with support from the New Jersey Department of Human Services Division of Mental Health and Addiction Services \nRegister Today: https://njpn.zoom.us/webinar/register/WN_4acYKQEbQ8i2xSj9CZ2JPQ \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOpening remarks by New Jersey Attorney General Matt Platkin \nModerated by Diane Litterer\, CEO of the New Jersey Prevention Network \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFeatured Speakers \nJillian Loyden \nFormer US Women’s National Team Goalkeeper\, Owner & Founder of The Keeper Institute \nAlexis M LaPietra\, DO\, FACEP \nMedical Director\, Addiction Medicine Emergency Service Line\, RWJBarnabas Health \nAngela Cicchino\, BA\, NCPRSS \nProgram Manager\, RWJBarnabas IFPR \nDr. Patricia Schram \nAssistant Professor of Pediatrics\, Harvard Medical School\, Addiction Medicine\, Developmental and Behavioral Pediatrics\, Adolescent Substance use and Addiction Program Boston Children’s Hospital \nErin Cohen\, CPS \nExecutive Director of Prevention Services\, Prevention Resources \nBrian Oliveira\, PharmD \nExecutive Director\, Garden State Pharmacy Owners \nDavid Nash\, Esq \nDirector of Legal Education and National Outreach\, Foundation for Educational Administration \nJanine Fabrizio \nTrainer\, NJPN
URL:https://www.addiction.rutgers.edu/event/njpn-webinar-play-and-protect-female-athletes-opioids/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240606T140000
DTEND;TZID=America/New_York:20240606T150000
DTSTAMP:20260424T040357
CREATED:20240529T154315Z
LAST-MODIFIED:20240529T154315Z
UID:7400-1717682400-1717686000@www.addiction.rutgers.edu
SUMMARY:UCSF Webinar - Mandatory Warning Signs for Cannabis Use in Pregnancy: Results from the Warning Sign Evidence\, Evaluation\, and Dissemination (WEED) Study
DESCRIPTION:The Warning Sign Evidence\, Evaluation\, and Dissemination (WEED) study\, led by Dr. Sarah Roberts at UCSF\, seeks to understand the impact of mandatory warning signs (MWS) for cannabis use during pregnancy and explore pregnant people’s perspectives on MWS. Join us to hear the results from this mixed-methods study and implications for cannabis policy. \nRegister here!
URL:https://www.addiction.rutgers.edu/event/ucsf-webinar-mandatory-warning-signs-for-cannabis-use-in-pregnancy-results-from-the-warning-sign-evidence-evaluation-and-dissemination-weed-study/
LOCATION:Virtual
END:VEVENT
END:VCALENDAR